PEN: Penumbra Inc

PEN新闻

• 15:40 GMED or PEN: Which Is the Better Value Stock Right Now?
• 15:30 Why Is Penumbra (PEN) Down 1.2% Since Last Earnings Report?
• 19:16 Baron Health Care Fund Q1 2026 Portfolio Activity
• 03:25 Diamond Hill Long-Short Strategy Q1 2026 Portfolio Movers: Gains, Drags, And Trades
• 21:25 Penumbra (PEN) Misses Q1 Earnings Estimates
• 15:40 ALC vs. PEN: Which Stock Should Value Investors Buy Now?
• 07:00 NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry
• 16:45 3 Reasons Why Penumbra (PEN) Is a Great Growth Stock
• 02:10 Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts
• 13:45 Here's Why Penumbra (PEN) is a Strong Growth Stock
• 16:45 3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
• 15:30 Penumbra (PEN) Down 1.6% Since Last Earnings Report: Can It Rebound?
• 12:49 Reasons to Retain Penumbra Stock in Your Portfolio for Now
• 13:10 Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates
• 16:45 Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"
• 13:37 瑞银重申Penumbra股票评级,对血栓切除术市场持乐观态度
• 13:32 UBS reiterates Penumbra stock rating on thrombectomy confidence
• 07:55 Fewer Deals, Bigger Stakes: Deciphering The 2026 M&A Landscape And The Rise Of Megadeals
• 12:41 PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise
• 16:42 UBS重申Penumbra股票中性评级,维持$374目标价
• 16:40 UBS reiterates Neutral on Penumbra stock, keeps $374 target
• 21:30 Compared to Estimates, Penumbra (PEN) Q4 Earnings: A Look at Key Metrics
• 21:15 Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates
• 20:12 Evercore ISI上调Penumbra目标价,看好栓塞治疗业务增长